20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Neuroprotective Role of GTS-21 in Combating Neurodegenerative Diseases

At NINGBO INNO PHARMCHEM CO.,LTD., we are deeply invested in supporting research that addresses the growing challenge of neurodegenerative diseases. GTS-21 powder, a compound known for its selective u03b17 nicotinic acetylcholine receptor agonism, is showing considerable promise in preclinical studies for its neuroprotective capabilities.

Neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's, are characterized by the progressive loss of neuronal structure and function. Finding effective treatments that can halt or even slow this degeneration is a global priority. GTS-21's mechanism of action, particularly its ability to modulate cholinergic systems and reduce inflammation, makes it a compelling candidate for therapeutic intervention in these conditions.

The neuroprotective effects of GTS-21 powder are thought to stem from its influence on pathways that protect neurons from oxidative stress, excitotoxicity, and inflammatory damage. By activating the u03b17 nAChR, GTS-21 may help to enhance neuronal survival and function. This makes it particularly relevant for conditions like Alzheimer's disease, where cognitive decline is closely linked to the health of cholinergic neurons.

The research into GTS-21 for Alzheimer's disease is focused on its potential to improve cognitive symptoms and possibly slow disease progression. Early findings suggest that GTS-21 and its active metabolite may offer benefits by enhancing synaptic plasticity and reducing neuroinflammation, both of which are implicated in Alzheimer's pathology. The ability to buy GTS-21 raw powder online from reputable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is crucial for researchers conducting these vital studies.

Furthermore, the broader neuroprotective qualities of GTS-21 are being explored for other neurological disorders where neuronal damage is a key feature. As research progresses, the role of selective u03b17 nAChR agonists like GTS-21 in the future of neurological medicine is becoming increasingly clear. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying the high-quality materials that drive this vital research forward.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Investigating GTS-21 Powder for Schizophrenia and Nicotine Dependence Treatment

Next: The Science of Nootropics: How GTS-21 Enhances Cognitive Function

All Rights Reserved